Chan Amy H Y, Katzer Caroline B, Horne Rob, Haughney John, Correia de Sousa Jaime, Williams Sian, Kaplan Alan
Centre of Behavioural Medicine, School of Pharmacy, UCL, London, United Kingdom.
Centre of Behavioural Medicine, School of Pharmacy, UCL, London, United Kingdom; International Primary Care Respiratory Group, London, United Kingdom.
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3482-3489.e1. doi: 10.1016/j.jaip.2020.07.014. Epub 2020 Jul 20.
Patient overreliance on short-acting beta agonists (SABA), with concomitant underuse of inhaled corticosteroids (ICS), is associated with poor asthma control and increased risk of asthma attacks.
To develop and validate a brief questionnaire to elicit patients' perceptions of SABA (eg, belief that asthma is best managed by SABA alone) that could lead them to be overly reliant on SABA.
The 5-item SABA Reliance Questionnaire (SRQ) was adapted from the well-validated Beliefs about Medicines Questionnaire assessing patient perceptions of the importance of, and necessity for, SABA in managing their asthma. The psychometric properties of the questionnaire were studied using Amazon Mechanical Turk, an online survey platform, in 446 people with self-reported asthma. Internal reliability and criterion-related validity were assessed on the basis of relationships between SRQ scores and other variables, including self-reported adherence to ICSs and perceived importance of reliever inhalers.
Internal reliability was good with Cronbach α = 0.74. Criterion-related validity was demonstrated by an inverse correlation between SRQ scores and self-reported adherence to ICSs (r = -0.291; P < .0001), and significant correlation between SRQ scores and perceived reliever importance (r = 0.216; P < .0001), as well as by significant differences in SRQ scores between those with high and those with low self-reported ICS adherence (adherence to ICS t = 4.825; P < .0001).
The SRQ demonstrated acceptable internal reliability, and criterion validity, supporting its potential use as a pragmatic tool for identifying patients whose beliefs are indicative of overreliance on SABA for asthma.
患者过度依赖短效β受体激动剂(SABA),同时吸入性糖皮质激素(ICS)使用不足,这与哮喘控制不佳及哮喘发作风险增加相关。
开发并验证一份简短问卷,以了解患者对SABA的认知(例如,认为哮喘仅通过SABA就能得到最佳控制的信念),这种认知可能导致他们过度依赖SABA。
5项SABA依赖问卷(SRQ)改编自经过充分验证的药物信念问卷,该问卷用于评估患者对SABA在哮喘管理中的重要性和必要性的认知。使用在线调查平台亚马逊土耳其机器人对446名自我报告患有哮喘的人进行研究,以了解该问卷的心理测量特性。基于SRQ得分与其他变量之间的关系评估内部信度和效标效度,这些变量包括自我报告的ICS依从性和缓解吸入器的感知重要性。
内部信度良好,Cronbach α = 0.74。SRQ得分与自我报告的ICS依从性呈负相关(r = -0.291;P <.0001),与缓解吸入器的感知重要性呈显著正相关(r = 0.216;P <.0001),以及自我报告的ICS依从性高和低的患者之间SRQ得分存在显著差异(ICS依从性t = 4.825;P <.0001),证明了效标效度。
SRQ显示出可接受的内部信度和效标效度,支持其作为一种实用工具用于识别那些其信念表明过度依赖SABA治疗哮喘的患者。